BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11903035)

  • 1. Rotavirus vaccine and the news media, 1987-2001.
    Danovaro-Holliday MC; Wood AL; LeBaron CW
    JAMA; 2002 Mar; 287(11):1455-62. PubMed ID: 11903035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intussusception among recipients of rotavirus vaccine: reports to the vaccine adverse event reporting system.
    Zanardi LR; Haber P; Mootrey GT; Niu MT; Wharton M
    Pediatrics; 2001 Jun; 107(6):E97. PubMed ID: 11389295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?
    Haber P; Chen RT; Zanardi LR; Mootrey GT; English R; Braun MM;
    Pediatrics; 2004 Apr; 113(4):e353-9. PubMed ID: 15060267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intussusception incidence relative to rotavirus vaccine use in Honolulu.
    Lee YY; Lee R; Yamamoto LG
    Clin Pediatr (Phila); 2005; 44(9):791-5. PubMed ID: 16327966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotavirus vaccines and intussusception risk.
    Bines JE
    Curr Opin Gastroenterol; 2005 Jan; 21(1):20-5. PubMed ID: 15687880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotavirus vaccination and intussusception: can we decrease temporally associated background cases of intussusception by restricting the vaccination schedule?
    Tai JH; Curns AT; Parashar UD; Bresee JS; Glass RI
    Pediatrics; 2006 Aug; 118(2):e258-64. PubMed ID: 16882770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rotavirus vaccines and vaccination in Latin America.
    Linhares AC; Bresee JS
    Rev Panam Salud Publica; 2000 Nov; 8(5):305-31. PubMed ID: 11190969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Intussusception with Rotavirus Vaccine.
    Kalaiselvan V; Thota P; Kumar V; Rathore MS; Thota A; Singh GN
    Indian J Pediatr; 2017 Feb; 84(2):97-100. PubMed ID: 27641974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withdrawal of rotavirus vaccine recommendation.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Nov; 48(43):1007. PubMed ID: 10577495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaches to monitoring intussusception following rotavirus vaccination.
    Tate JE; Parashar UD
    Expert Opin Drug Saf; 2019 Jan; 18(1):21-27. PubMed ID: 30570424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America.
    Desai R; Parashar UD; Lopman B; de Oliveira LH; Clark AD; Sanderson CF; Tate JE; Matus CR; Andrus JK; Patel MM
    Clin Infect Dis; 2012 May; 54(10):1397-405. PubMed ID: 22431803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of Post-Licensure Data on Benefits and Risks of Vaccination to Inform Vaccine Policy: The Example of Rotavirus Vaccines.
    Parashar UD; Cortese MM; Payne DC; Lopman B; Yen C; Tate JE
    Am J Prev Med; 2015 Dec; 49(6 Suppl 4):S377-82. PubMed ID: 26590437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National Immunization Information Hotline: Calls concerning adverse events, 1998-2000.
    Gust DA; Gangarosa P; Hibbs B; Pollard R; Wallach G; Chen RT
    J Health Commun; 2004; 9(5):387-94. PubMed ID: 15513788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intussusception and rotavirus vaccination: a review of the available evidence.
    Patel MM; Haber P; Baggs J; Zuber P; Bines JE; Parashar UD
    Expert Rev Vaccines; 2009 Nov; 8(11):1555-64. PubMed ID: 19863248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007.
    Haber P; Patel M; Izurieta HS; Baggs J; Gargiullo P; Weintraub E; Cortese M; Braun MM; Belongia EA; Miller E; Ball R; Iskander J; Parashar UD
    Pediatrics; 2008 Jun; 121(6):1206-12. PubMed ID: 18519491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception.
    Patel MM; Clark AD; Glass RI; Greenberg H; Tate J; Santosham M; Sanderson CF; Steele D; Cortese M; Parashar UD
    Vaccine; 2009 May; 27(22):2916-22. PubMed ID: 19428901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. News media coverage of screening mammography for women in their 40s and tamoxifen for primary prevention of breast cancer.
    Schwartz LM; Woloshin S
    JAMA; 2002 Jun; 287(23):3136-42. PubMed ID: 12069679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rotavirus vaccines: targeting the developing world.
    Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
    J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective hospital based surveillance of intussusception in children in a sentinel paediatric hospital: benefits and pitfalls for use in post-marketing surveillance of rotavirus vaccines.
    Lloyd-Johnsen C; Justice F; Donath S; Bines JE
    Vaccine; 2012 Apr; 30 Suppl 1():A190-5. PubMed ID: 22520131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of post-licensure data on benefits and risks of vaccination to inform vaccine policy: The example of rotavirus vaccines.
    Parashar UD; Cortese MM; Payne DC; Lopman B; Yen C; Tate JE
    Vaccine; 2015 Nov; 33 Suppl 4():D55-9. PubMed ID: 26122581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.